Erdaini
Erdafitinib
- Concentración
- 3mg/4mg/5mg
- Fabricante
- TLPH Pharma
- Disponibilidad
- Disponible para obtener
Erdafitinib 3mg/4mg/5mg — Tablet, 28's Pot
¿Necesita ayuda?
Nuestro equipo de soporte multilingüe puede ayudarle con disponibilidad, envío y pedidos.
Chatear por WhatsApp
Escanear para WeChat
Sobre este medicamento
Originator: Balversa by Janssen · Manufacturer: TLPH Pharma. Indication & Dosage: Erdaini (Erdafitinib), generic Balversa is a prescription medicine used to treat adult patients with locally advanced or metastatic Urothelial Carcinoma (bladder cancer) that has susceptible FGFR3 or FGFR2 genetic alterations and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy. Erdaini manufactured by TLPH Pharma in Laos. Erdafitinib has to take orally once daily with or without food. Side Effects: The most common adverse reactions of Erdafitinib are: Nausea , vomiting , mouth sores/pain , change in how food tastes, abdominal pain, diarrhea, constipation, loss of appetite, weight loss, tiredness, dry mouth/skin, or muscle/joint pain. The above information comes from the Internet. Please consult with doctor for medical advice.
Indicaciones
Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.
